Showing 6931-6940 of 18629 results for "".
Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
https://reachmd.com/clinical-practice/psychiatry-and-mental-health/valbenazine-for-td-consistent-long-term-efficacy-across-racial-and-ethnic-subgroups-in-kinect-4/37642/Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4What Challenges and Triumphs Do Patients Face While Living With PAH?
https://reachmd.com/programs/cme/what-challenges-and-triumphs-do-patients-face-while-living-with-pah/33242/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
https://reachmd.com/programs/cme/the-latest-patient-centered-recommendations-from-the-7th-world-symposium-on-ph/33236/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.Aligning PAH Treatment Plans With Key Care Goals and Your Patients’ Priorities
https://reachmd.com/programs/cme/aligning-pah-treatment-plans-with-key-care-goals-and-your-patients-priorities/33238/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
https://reachmd.com/programs/cme/qol-matters-brain-stem-stimulation-in-patients-with-unipolar-depression/35796/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
https://reachmd.com/programs/project-oncology/newly-diagnosed-multiple-myeloma-the-prognostic-significance-of-lymphopenia/30047/A recent study examined how absolute lymphocyte count correlates with overall survival in newly diagnosed multiple myeloma—here’s what it found.Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
https://reachmd.com/programs/neurofrontiers/zilucoplan-a-promising-potential-treatment-for-myasthenia-gravis/26392/Dive into a recent study that suggests zilucoplan could help treat MG symptoms.A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
https://reachmd.com/programs/the-drug-report/a-guide-for-off-label-use-of-treatments-for-covid-19-from-the-ashp/11412/Recommendations for using experimental treatments during the COVID-19 pandemic were recently published. Here’s what they say.Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages
https://reachmd.com/programs/cme/diagnostic-and-diagnosis-logistics-navigating-complexity-across-ages/39028/Tune in to explore age-related diagnostic considerations and confirmation strategies for generalized myasthenia gravis.The Clinical Weight of TTR: What the Latest Data Reveal
https://reachmd.com/programs/cme/the-clinical-weight-of-ttr-what-the-latest-data-reveal/35934/Review emerging data on acoramidis and TTR levels in ATTR-CM, exploring associations with AFib, survival outcomes, biomarkers, and comorbidity burden.